|
[1]
|
Steeg, P.S. (2006) Tumor Metastasis: Mechanistic Insights and Clinical Challenges. Nature Medicine, 12, 895-904. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, E.I. and Yates III, J.R. (2006) Maspin and Tumor Metastasis. IUBMB Life, 58, 25-29. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jiang, M., Chen, Y., Zhang, Y., Chen, L., Zhang, N., Huang, T., Cai, Y.-D. and Kong, X. (2013) Identification of Hepatocellular Carcinoma Related Genes with k-th Shortest Paths in a Protein-Protein Interaction Network. Molecular BioSystems, 9, 2720-2728. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Guo, W., Shang, D.-M., Cao, J.-H., Feng, K., He, Y.-C., Jiang, Y., Wang, S. and Gao, Y.-F. (2017) Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart Algorithm. BioMed Research International, 2017, Article ID: 6132436. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Luo, H., Wang, J., Li, M., Luo, J., Ni, P., Zhao, K., Wu, F.-X. and Pan, Y. (2018) Computational Drug Repositioning with Random Walk on a Heterogeneous Network. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 16, 1890-1900. [Google Scholar] [CrossRef]
|
|
[6]
|
Yu, W., Zhang, Z., Min, D., Yang, Q., Du, X., Tang, L., Lin, F., Sun, Y., Zhao, H. and Zheng, S. (2014) Mediator of RNA Polymerase II Transcription Subunit 19 Promotes Osteo-sarcoma Growth and Metastasis and Associates with Prognosis. European Journal of Cancer, 50, 1125-1136. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Christgen, M., Bartels, S., Luft, A., Persing, S., Henkel, D., Leh-mann, U. and Kreipe, H. (2018) Activating Human Epidermal Growth Factor Receptor 2 (HER2) Gene Mutation in Bone Metastases from Breast Cancer. Virchows Archiv, 473, 577-582. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fu, W., Wu, H., Cheng, Z., Huang, S. and Rao, H. (2018) The Role of Katanin p60 in Breast Cancer Bone Metastasis. Oncology Letters, 15, 4963-4969. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kim, J., Kim, Y., Choi, H., Kwon, A., Jekarl, D.W., Lee, S., Jang, W., Chae, H., Kim, J.R. and Kim, J.M. (2018) Ubiquitin C Decrement Plays a Pivotal Role in Replicative Senescence of Bone Marrow Mesenchymal Stromal Cells. Cell Death & Disease, 9, Article No. 139. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Najar, M., Fayyad-Kazan, H., Faour, W.H., Badran, B., Journe, F. and Lagneaux, L. (2017) Breast Cancer Cells and Bone Marrow Mesenchymal Stromal Cells: A Regulated Modulation of the Breast Tumor in the Context of Immune Response. Inflammation Research, 66, 129-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Johnson, R.W., Merkel, A.R., Page, J.M., Ruppender, N.S., Guelcher, S.A. and Sterling, J.A. (2014) Wnt Signaling Induces Gene Expression of Factors Associated with Bone De-struction in Lung and Breast Cancer. Clinical & Experimental Metastasis, 31, 945-959. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tulotta, C. and Ottewell, P. (2018) The Role of IL-1B in Breast Cancer Bone Metastasis. Endocrine-Related Cancer, 25, R421-R434. [Google Scholar] [CrossRef]
|
|
[13]
|
Hofer, E.L., Russa, V.L., Honegger, A.E., Bullorsky, E.O., Bordenave, R.H. and Chasseing, N.A. (2005) Alteration on the Expression of IL-1, PDGF, TGF-β, EGF, and FGF Receptors and c-Fos and c-Myc Proteins in Bone Marrow Mesenchymal Stroma Cells from Advanced Untreated Lung and Breast Cancer Patients. Stem Cells and Development, 14, 587-594. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
El Hamidieh, A., Grammatikakis, N. and Patsavoudi, E. (2012) Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion. PLOS ONE, 7, e42722. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Holen, I., Nutter, F., Wilkinson, J., Evans, C., Avgoustou, P. and Ottewell, P.D. (2015) Human Breast Cancer Bone Metastasis in Vitro and in Vivo: A Novel 3D Model System for Studies of Tumour Cell-Bone Cell Interactions. Clinical & Ex-perimental Metastasis, 32, 689-702. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Nutter, F., Holen, I., Brown, H.K., Cross, S.S., Evans, C.A., Walker, M., Coleman, R.E., Westbrook, J.A., Selby, P.J. and Brown, J.E. (2014) Dif-ferent Molecular Profiles Are Associated with Breast Cancer Cell Homing Compared with Colonisation of Bone: Evi-dence Using a Novel Bone-Seeking Cell Line. Endocrine-Related Cancer, 21, 327-341. [Google Scholar] [CrossRef]
|
|
[17]
|
Zhou, R., Frum, R., Deb, S. and Deb, S.P. (2005) The Growth Arrest Function of the Human Oncoprotein Mouse Double Minute-2 Is Disabled by Downstream Mutation in Cancer Cells. Cancer Research, 65, 1839-1848. [Google Scholar] [CrossRef]
|
|
[18]
|
Martinez, R., Blasina, A., Hallin, J.F., Hu, W., Rymer, I., Fan, J., Hoffman, R.L., Murphy, S., Marx, M. and Yanochko, G. (2015) Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology Which Impacts Clinical Utility. PLOS ONE, 10, e0138616. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Liu, H., Radisky, D.C., Yang, D., Xu, R., Radisky, E.S., Bissell, M.J. and Bishop, J.M. (2012) MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of α v and β 3 Integrin Subunits. Nature Cell Biology, 14, 567-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhao, J. and Jiang, G. (2018) MiR-4282 Inhibits Proliferation, Invasion and Metastasis of Human Breast Cancer by Targeting Myc. European Review for Medical and Pharmacological Sciences, 22, 8763-8771.
|
|
[21]
|
Nasrazadani, A. and Van den Berg, C. (2010) Abstract P4-06-02: Systemic Deletion of c-Jun N-Terminal Kinase 1 or 2 Is Protective in Breast Cancer Bone Metastasis. Cancer Research, 70, P4-06-02. [Google Scholar] [CrossRef]
|
|
[22]
|
Qiao, H., Cui, Z., Yang, S., Ji, D., Wang, Y., Yang, Y., Han, X., Fan, Q., Qin, A. and Wang, T. (2017) Targeting Osteocytes to Attenuate Early Breast Cancer Bone Me-tastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release. ACS Nano, 11, 7259-7273. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Gayer, C.P., Craig, D.H., Flanigan, T.L., Reed, T.D., Cress, D.E. and Basson, M.D. (2010) ERK Regulates Strain-Induced Migration and Proliferation from Different Subcellular Locations. Journal of Cellular Biochemistry, 109, 711-725. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Zhao, J., Chen, H.-F. and Deng, H.-Y. (2009) Effects of Inhibiting JAK on Invasion and Metastasis of the Human Breast Cancer Cells through ERK Signaling Transduction Pathway. Chinese Journal of Cancer Research, 21, 32-36. [Google Scholar] [CrossRef]
|
|
[25]
|
Li, Y.-B., Zhang, J.-P., Yao, W., Wang, H., Tang, J.-M. and Yang, J.-Y. (2010) VEGF Promote Migration of Bone Marrow-Derived Mesenchymal Stem Cells through PKC Signal Pathway. Journal of Yunyang Medical College, No. 3, 2.
|
|
[26]
|
Doucet, M., Kominsky, S., Nell, D. and Weber, K. (2005) TGF-Beta Stimulates IL-6, PDGF-AA, and VEGF in Renal Cell Carcinoma Bone Metastasis. Journal of Bone and Mineral Research, 20, S33.
|
|
[27]
|
Hill, A., McFarlane, S., Johnston, P. and Waugh, D. (2008) CD44 Signalling Increases Cathepsin K and MT1MMP Expression to Potentiate Breast Cancer Cell Invasion through Collagen I. Breast Cancer Research, 10, P33. [Google Scholar] [CrossRef]
|
|
[28]
|
Hill, A., McFarlane, S., Johnston, P. and Waugh, D. (2006) CD44 Regulates the Expression of the Cysteine Protease Cathepsin K: Implications for Bone Metastasis of Breast Cancer. European Journal of Cancer Supplements, 4, 17. [Google Scholar] [CrossRef]
|
|
[29]
|
Liu, Y., Qing, H., Su, X., Wang, C., Li, Z. and Liu, S. (2015) Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 21, 2694-2700. [Google Scholar] [CrossRef]
|
|
[30]
|
Chang, Y.-S., Chen, W.-Y., Yin, J. J., Sheppard-Tillman, H., Huang, J. and Liu, Y.-N. (2015) EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Acti-vating TWIST1. Cancer Research, 75, 3077-3086. [Google Scholar] [CrossRef]
|
|
[31]
|
Wang, S.-J., Saadi, W., Lin, F., Nguyen, C.M.-C. and Jeon, N.L. (2004) Differential Effects of EGF Gradient Profiles on MDA-MB-231 Breast Cancer Cell Chemotaxis. Experi-mental Cell Research, 300, 180-189. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Nasrazadani, A. and Van Den Berg, C.L. (2011) c-Jun N-Terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis. Genes & Cancer, 2, 31-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Xu, J., Ying, Y., Xiong, G., Lai, L., Wang, Q. and Yang, Y. (2019) Amyloid β Precursor Protein Silencing Attenuates Epithelial-Mesenchymal Transition of Nasopharyngeal Car-cinoma Cells via Inhibition of the MAPK Pathway. Molecular Medicine Reports, 20, 409-416. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Lim, S., Yoo, B.K., Kim, H.-S., Gilmore, H.L., Lee, Y., Lee, H.-P., Kim, S.-J., Letterio, J. and Lee, H.-G. (2014) Amyloid-β Precursor Protein Promotes Cell Proliferation and Motility of Advanced Breast Cancer. BMC Cancer, 14, Article No. 928. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Sohara, Y., Peng, H., Minkin, C., Nolta, J., Wang, H., Dorey, F., Reynolds, P., Shimada, H. and DeClerck, Y. (2004) Contribution of Bone Marrow Mesenchymal Stem Cells and IL-6 to Bone Metastasis. Journal of Bone and Mineral Research, 19, 1577.
|
|
[36]
|
Wu, C., Chen, M., Sun, Z., Ye, Y., Han, X., Qin, Y. and Liu, S. (2019) Wenshen Zhuanggu Formula Mitigates Breast Cancer Bone Metastasis through the Signaling Crosstalk among the Jagged1/Notch, TGF-β and IL-6 Signaling Pathways. Journal of Ethnopharmacology, 232, 145-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Kijewska, M., Viski, C., Turrell, F., Fitzpatrick, A., van Weverwijk, A., Gao, Q., Iravani, M. and Isacke, C.M. (2019) Using an In-Vivo Syngeneic Spontaneous Metastasis Model Identifies ID2 as a Promoter of Breast Cancer Colonisation in the Brain. Breast Cancer Research, 21, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Buijs, J.T., Henriquez, N.V., van Overveld, P.G., van der Horst, G., Ten Dijke, P. and van der Pluijm, G. (2007) TGF-β and BMP7 Interactions in Tumour Progression and Bone Metastasis. Clinical & Experimental Metastasis, 24, 609-617. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Zhu, S., Sachdeva, M., Wu, F., Lu, Z. and Mo, Y.-Y. (2010) Ubc9 Promotes Breast Cell Invasion and Metastasis in a Sumoylation-Independent Manner. Oncogene, 29, 1763-1772. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Teramachi, J., Silbermann, R., Yang, P., Zhao, W., Mohammad, K.S., Guo, J. anderson, J.L., Zhou, D., Feng, R., Myint, K.Z., Maertz, N., Beumer, J.H., Eiseman, J.L., Windle, J.J., Xie, X.Q., Roodman, G.D. and Kurihara, N. (2016) Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation in Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones in Vivo. Leukemia, 30, 390-398. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Fan, Q.M., Yue, B., Bian, Z.Y., Xu, W.T., Tu, B., Dai, K.R., Li, G. and Tang, T.T. (2012) The CREB-Smad6-Runx2 Axis Contributes to the Impaired Osteogenesis Potential of Bone Marrow Stromal Cells in Fibrous Dysplasia of Bone. The Journal of Pathology, 228, 45-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Chen, X., Qiu, J., Yang, D., Lu, J., Yan, C., Zha, X. and Yin, Y. (2013) MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9. PLOS ONE, 8, e78794. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Qian, G., Hao, S., Yang, D. and Meng, Q. (2015) P15, MDM2, NF-κB, and Bcl-2 Expression in Primary Bone Tumor and Correlation with Tumor Formation and Metastasis. International Journal of Clinical and Experimental Pathology, 8, 14885-14892.
|
|
[44]
|
Cizkova, M., Vacher, S., Meseure, D., Trassard, M., Susini, A., Mlcuchova, D., Callens, C., Rouleau, E., Spyratos, F. and Lidereau, R. (2013) PIK3R1 Underexpression Is an Independent Prognostic Marker in Breast Cancer. BMC Cancer, 13, Article No. 545. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Van Allen, E., Foye, A., Wagle, N., Kim, W., Carter, S., McKenna, A., Simko, J., Garraway, L. and Febbo, P. (2014) Successful Whole-Exome Sequencing from a Prostate Cancer Bone Metastasis Biopsy. Prostate Cancer and Prostatic Diseases, 17, 23-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Ruiz-Garcia, E., Scott, V., Machavoine, C., Bidart, J., Lacroix, L., Delaloge, S. and Andre, F. (2010) Gene Expression Profiling Identifies Fibronectin 1 and CXCL9 as Candidate Biomarkers for Breast Cancer Screening. British Journal of Cancer, 102, 462-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
von Au, A., Vasel, M., Tiwari, S., Glüer, C. and Nakchbandi, I. (2010) Source and Significance of Circulating Fibronectin in Breast Cancer-Induced Bone Metastasis. Bone, 47, S113. [Google Scholar] [CrossRef]
|
|
[48]
|
Wang, J., Fu, L., Gu, F. and Ma, Y. (2011) Notch1 Is Involved in Migration and Invasion of Human Breast Cancer Cells. Oncology Reports, 26, 1295-1303.
|
|
[49]
|
Pei, J. and Wang, B. (2015) Notch-1 Promotes Breast Cancer Cells Proliferation by Regulating LncRNA GAS5. International Journal of Clinical and Experimental Medicine, 8, 14464-14471.
|
|
[50]
|
Kong, P., Chen, L., Yu, M., Tao, J., Liu, J., Wang, Y., Pan, H., Zhou, W. and Wang, S. (2018) miR-3178 Inhibits Cell Proliferation and Metastasis by Targeting Notch1 in Triple-Negative Breast Cancer. Cell Death & Disease, 9, Article No. 1059. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wang, L., Zhang, J., Wan, L., Zhou, X., Wang, Z. and Wei, W. (2015) Targeting Cdc20 as a Novel Cancer Therapeutic Strategy. Pharmacology & Therapeutics, 151, 141-151. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Liu, G., Chen, Y., Qi, F., Jia, L., Lu, X.A., He, T., Fu, Y., Li, L. and Luo, Y. (2015) Specific Chemotherapeutic Agents Induce Metastatic Behaviour through Stromal- and Tumour-Derived Cytokine and Angiogenic Factor Signalling. The Journal of Pathology, 237, 190-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Li, R., Peng, C., Zhang, X., Wu, Y., Pan, S. and Xiao, Y. (2017) Roles of Arf6 in Cancer Cell Invasion, Metastasis and Proliferation. Life Sciences, 182, 80-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Xu, R., Zhang, Y., Gu, L., Zheng, J., Cui, J., Dong, J. and Du, J. (2015) Arf6 Regulates EGF-Induced Internalization of E-Cadherin in Breast Cancer Cells. Cancer Cell International, 15, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Morrison, M.M., Young, C.D., Wang, S., Sobolik, T., Sanchez, V.M., Hicks, D.J., Cook, R.S. and Brantley-Sieders, D.M. (2015) mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis. PLoS Genetics, 11, e1005291. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Zheng, H. and Kang, Y. (2015) Cradle of Evil: Osteogenic Niche for Early Bone Metastasis. Cancer Cell, 27, 153-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Chou, C.-P., Huang, N.-C., Jhuang, S.-J., Pan, H.-B., Peng, N.-J., Cheng, J.-T., Chen, C.-F., Chen, J.-J. and Chang, T.-H. (2014) Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions. PLOS ONE, 9, e93934. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Carthew, R.W., Chodosh, L.A. and Sharp, P.A. (1985) An RNA Polymerase II Transcription Factor Binds to an Upstream Element in the Adenovirus Major Late Promoter. Cell, 43, 439-448. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Hu, K.-F., Kong, X.-Y., Zhong, M.-C., Wan, H.-Y., Lin, N. and Pei, X.-H. (2017) Brucine Inhibits Bone Metastasis of Breast Cancer Cells by Suppressing Jagged1/Notch1 Signaling Pathways. Chinese Journal of Integrative Medicine, 23, 110-116. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Chen, X., Pei, Z., Peng, H. and Zheng, Z. (2018) Exploring the Molecular Mechanism Associated with Breast Cancer Bone Metastasis Using Bioinformatic Analysis and Microarray Genetic Interaction Network. Medicine, 97, e12032. [Google Scholar] [CrossRef]
|
|
[61]
|
Wu, X., Sun, L., Wang, X., Su, P., Li, Z., Zhang, C., Wang, Y., Gao, P. and Ma, R. (2016) Breast Cancer Invasion and Metastasis by mPRα through the PI3K/Akt Signaling Pathway. Pathology & Oncology Research, 22, 471-476. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Kalantzaki, K., Koumakis, L., Bei, E.S., Zervakis, M., Potamias, G. and Kafetzopoulos, D. (2013) Experimental Model Construction and Validation of the ErbB Signaling Pathway. 13th IEEE International Conference on BioInformatics and BioEngineering, Chania, 10-13 November 2013, 1-4. [Google Scholar] [CrossRef]
|
|
[63]
|
Li, X.-Q., Du, X., Li, D.-M., Kong, P.-Z., Sun, Y., Liu, P.-F., Wang, Q.-S. and Feng, Y.-M. (2015) ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. Cancer Research, 75, 3302-3313. [Google Scholar] [CrossRef]
|
|
[64]
|
Drabsch, Y. and Ten Dijke, P. (2011) TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis. Journal of Mammary Gland Biology and Neoplasia, 16, 97-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Ferreira Tojais, N., Peghaire, C., Franzl, N., Larrieu-Lahargue, F., Jaspard, B., Reynaud, A., Moreau, C., Couffinhal, T., Duplàa, C. and Dufourcq, P. (2014) Frizzled7 Controls Vascular Permeability through the Wnt-Canonical Pathway and Cross-Talk with Endothelial Cell Junction Complexes. Cardiovascular Research, 103, 291-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Chen, Y., Shi, H.Y., Stock, S.R., Stern, P.H. and Zhang, M. (2011) Regulation of Breast Cancer-Induced Bone Lesions by β-Catenin Protein Signaling. Journal of Biological Chemistry, 286, 42575-42584. [Google Scholar] [CrossRef]
|
|
[67]
|
Oh, C., Park, S., Lee, E.K. and Yoo, Y.J. (2013) Downregulation of Ubiquitin Level via Knockdown of Polyubiquitin Gene Ubb as Potential Cancer Therapeutic Intervention. Scientific Reports, 3, Article No. 2623. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
He, R., Yang, N., Zhang, P., Liu, J., Li, J., Zhou, F. and Zhang, W. (2017) Identification and Expression of MMSA-8, and Its Clinical Significance in Multiple Myeloma. Oncology Reports, 37, 3235-3243. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Wang, H., Yu, J., Zhang, L., Xiong, Y., Chen, S., Xing, H., Tian, Z., Tang, K., Wei, H. and Rao, Q. (2014) RPS27a Promotes Proliferation, Regulates Cell Cycle Progression and Inhibits Apoptosis of Leukemia Cells. Biochemical and Biophysical Research Communications, 446, 1204-1210. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Chen, W., Zhang, L., Wang, Y., Sun, J., Wang, D., Fan, S., Ban, N., Zhu, J., Ji, B. and Wang, Y. (2016) Expression of CDC5L Is Associated with Tumor Progression in Gliomas. Tumor Biology, 37, 4093-4103. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Lu, X.-Y., Lu, Y., Zhao, Y.-J., Jaeweon, K., Kang, J., Li, X.-N., Ge, G., Meyer, R., Perlaky, L. and Hicks, J. (2008) Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma. Molecular Cancer Research, 6, 937-946. [Google Scholar] [CrossRef]
|
|
[72]
|
Xu, J., Liu, Y., Li, Y., Wang, H., Stewart, S., Van der Jeught, K., Agarwal, P., Zhang, Y., Liu, S. and Zhao, G. (2019) Precise Targeting of POLR2A as a Therapeutic Strategy for Human Triple Negative Breast Cancer. Nature Nanotechnology, 14, 388-397. [Google Scholar] [CrossRef] [PubMed]
|